Skip to main content
SpringerLink
Log in
Book cover

Difficult Decisions in Endocrine Surgery pp 423–430Cite as

Surgery Versus Observation for Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors

  • Chapter
  • First Online:

  • 664 Accesses

Part of the book series: Difficult Decisions in Surgery: An Evidence-Based Approach ((DDSURGERY))

Abstract

Non-functioning pancreatic neuroendocrine tumors account for 2% of all pancreatic malignancies, most of them are benign and sporadic. The most common image studies for their characterization are CT, MRI, endoscopic ultrasound, and PET. Serum Chromogranine A is the most common tumor marker for PNETs and it is used for the diagnosis as well as for surveillance. Surgical resection, either open or laparoscopic is the treatment of choice for all symptomatic sporadic tumors as well as for malignant tumors in the absence of extra pancreatic extension, lymph node or hepatic metastases.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Massironi S, Sciola V, Peracchi M, Ciafardini C, Spampatti MP, Conte D. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol. 2008;14(35):5377–84.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Godsmith SJ, Klimstra DS, et al. NANETS treatment guidelines: well-differenciated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010;39(6):735–52.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Franko J, Weantao F, Genovese E, Moser J. Non functional neuroendocrine carcinoma of the páncreas: incidence, tumor biology and outcomes in 2158 patients. J Gastrointest Surg. 2009;14(3):541–8.

    Article  PubMed  Google Scholar 

  4. Herrera MF, Akerstrom G, Angelos P, Grant CS, Hoff AO, Pantoja JP, et al. AACE/ACE disease state clinical review: pancreatic neuronedocrine incidentalomas. Endocr Pract. 2015;21:546–53.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063.

    Article  PubMed  Google Scholar 

  6. Kent RB, Van Heerden JA, Weiland LH. Nonfuctionning islet cell tumors. Ann Surg. 1981;193:185–90.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bilimoria KY, Tomlinson JS, Merkow RP. Clinocopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9821 patients. J Gastrointest Surg. 2007;11:1460–7.

    Article  PubMed  Google Scholar 

  8. Falconi M, Barstsch DF, Eriksson B, et al. ENETS concensus guidelines for the management of patients with digestive neuroendocrine neoplasm of the digestive system: well differenciated pancreatic non-functionning tumors. Neuroendocrinology. 2012;95:120–34.

    Article  CAS  PubMed  Google Scholar 

  9. Halfdanarson TR, Rabe KG, Rubin J, et al. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008;19(10):1727–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Yan M, Zeng L, Zhang Y, et al. Surgical treatment and clinical outcomes of nonfunctional pancreatic neuroendocrine tumors. A 14 year experience from a single center. Medicine. 2014;93(22):1–7.

    Google Scholar 

  11. Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707–12.

    Google Scholar 

  12. Gullo L, Migliori M, Falconi M, et al. Nonfunctioning pancreatic tumors: a multicenter clínical study. Am J Gastroent. 2003;98(11):2435–9.

    Article  PubMed  Google Scholar 

  13. Phan GQ, Yeo CJ, Hruban RH, et al. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg. 1998;2(5):473–82.

    Article  CAS  PubMed  Google Scholar 

  14. Kuo J, Lee J, Chabot J. Nonfunctional pancreatic neuroendocrine tumors. Surg Clin North Am. 2014;94(3):689–708.

    Article  PubMed  Google Scholar 

  15. Kartalis N, Pozzi RM, Sundin A. Recent developments in imaging of pancreatic neuroendocrine tumors. Ann Gastroenterol. 2015;28(2):193–202.

    PubMed  PubMed Central  Google Scholar 

  16. Hochwald S, Conlon K, Brennan M. Nonfunctional pancreatic islet cell tumors. In: Doherty G, Skogseid B, editors. Surgical endocrinology. Philadelphia: Lippincot Williams &Wilkins; 2001. p. 362–73.

    Google Scholar 

  17. Sundin A, Vullierme MP, Kaltsas G, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological examinations. Neuroendocrinology. 2009;90(2):167–83.

    Article  CAS  PubMed  Google Scholar 

  18. Chatzipantelis P, Salla C, Konstantinou P, et al. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases. Cancer. 2008;114(4):255–62.

    Article  PubMed  Google Scholar 

  19. Miderer M, Weber MM, Fottner C. Molecular imaging of gastroenteropancreatic neuroendocrine tumors. Gastroenterol Clin N Am. 2010;39:923–35.

    Article  Google Scholar 

  20. Ter-Minassian M, Chan J, Hooshmand S, et al. Clinial presentation, survival and recurrence in patients with neuroendocrine tumors: results from a prospective institutional database. Endocr Relat Cancer. 2013;20:187–96.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Bettini R, Boninsegna L, Mantovani W, et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non functioning pancreatic endocrine tumors. Ann Oncol. 2008;19:903–8.

    Article  CAS  PubMed  Google Scholar 

  22. Touzios JG, Kiely JM, Pitt SC, et al. Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg. 2005;241:776–85.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lee LC, Grant CS, Salomao DR, et al. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role of non-operative management. Surgery. 2012;152:965–74.

    Article  PubMed  Google Scholar 

  24. Sallinen V, Haglund C, Sepannen H. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: do size and symptoms matter? Surgery. 2015;158(6):1556–63.

    Article  PubMed  Google Scholar 

  25. Gaujoux S, Partelli S, Maire F, et al. Observational study of natural history of small sporadic nonfuntioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab. 2013;98(12):4784–9.

    Article  CAS  PubMed  Google Scholar 

  26. Zhang IY, Fernandez-del Castillo C, Zhao J, et al. Operative vs. non-operative management of nonfunctioning pancreatic neuroendocrine tumors. In: 49th annual meeting of the pancreas club syllabus. 2015. p. S001.

    Google Scholar 

  27. Falconi M, Plockinger U, Kwekkemboom D, et al. Well differenciated pancreatic nonfunctioning tumors/carcinoma, ENETS guidelines. Neuroendocrinology. 2006;84:196–211.

    Article  CAS  PubMed  Google Scholar 

  28. Kim MJ, Choi DW, Heo JS, et al. Surgical strategies for nonfunctioning pancreatic neuroendocrine tumors. Br J Surg. 2012;99:1562–8.

    Article  CAS  PubMed  Google Scholar 

  29. Sharpe SM, In H, Winchester DJ, Talamonti MS, et al. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors. J Gastrointest Surg. 2015;19:117–23.

    Article  PubMed  Google Scholar 

  30. Solorzano CC, Lee JE, Pisters PWT, et al. Nonfunctioning islet cell carcinoma of the páncreas: survival results in a contemporary series of 163 patiens. Surgery. 2011;130:1078–85.

    Article  Google Scholar 

  31. Toumpanakis C, Meyer T, Caplin ME. Citotoxic treatment including embolization/chemoembolization for neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab. 2007;21:131.

    Article  CAS  PubMed  Google Scholar 

  32. Moertel CG, Lefkopoulo M, Lipsitz S, et al. Streptozocina-doxorubicina, streptozocina-fluoracil or chlorozotocina in the treatment of advanced islet cell carcinoma. N Engl J Med. 1992;326:519–23.

    Article  CAS  PubMed  Google Scholar 

  33. Moertel CG, Kvols LK, Oconnell MJ, et al. Treatment of neuroendocrine carcinoma with combined etoposide and cisplatin. Cancer. 1991;68:227.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Instituto Guatemalteco de Seguridad Social, Guatemala City, Guatemala

    Carlos R. Cordón-Fernández

  2. UNAM at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Miguel F. Herrera

Authors
  1. Carlos R. Cordón-Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miguel F. Herrera
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Surgery and MacLean Center for Clinical Medical Ethics, The University of Chicago, Chicago, IL, USA

    Peter Angelos

  2. Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA

    Raymon H. Grogan

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cordón-Fernández, C.R., Herrera, M.F. (2018). Surgery Versus Observation for Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors. In: Angelos, P., Grogan, R. (eds) Difficult Decisions in Endocrine Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-319-92860-9_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92860-9_34

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92858-6

  • Online ISBN: 978-3-319-92860-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation